Home › Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse
 

Keywords :   


Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse

2015-09-30 08:19:49| drugdiscoveryonline News Articles

Sosei Group Corporation is pleased to announce that its wholly-owned subsidiary Heptares Therapeutics (“Heptares”) has been awarded a grant from the National Institute on Drug Abuse (NIDA), one of the US National Institutes of Health

Tags: research development national abuse

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
26.06LG and Blacknut provide cloud video games through webOS
26.06Universal UK resort to open 365 days a year
26.06Steelwork closures' ripple effect on town's wages
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
More »